<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for SB 3868         </title>
<shortdesc>ACCESS TO AFFORDABLE DRUGS</shortdesc>
<sponsor>
<sponsorhead1>Senate Sponsors</sponsorhead1><sponsors>Sen. Jacqueline Y. Collins</sponsors>
</sponsor>
<lastaction>
<statusdate>1/13/2021</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>New Act</reference><aliasreference></aliasreference><SynopsisText>Creates the Preserving Access to Affordable Drugs Act. Provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim in connection with the sale of a pharmaceutical product is presumed to have anticompetitive effects and is a violation of the Act if certain circumstances apply. Provides other requirements for patent infringement claims in connection with the sale of a pharmaceutical product. Contains provisions regarding presumptions in an action under the Act. Provides civil penalties for violating the Act. Provides that any penalty shall accrue only to the State of Illinois and shall be recovered in a civil action brought by the Attorney General against any party to an agreement that violates this Act. Requires an action to enforce a cause of action for a violation of the Act to be commenced within 4 years after the cause of action accrued. Contains other provisions.</SynopsisText></synopsis>
<actions>
<statusdate>2/14/2020</statusdate><chamber>Senate</chamber><action>Filed with Secretary by Sen. Jacqueline Y. Collins</action>
<statusdate>2/14/2020</statusdate><chamber>Senate</chamber><action>First Reading</action>
<statusdate>2/14/2020</statusdate><chamber>Senate</chamber><action>Referred to Assignments</action>
<statusdate>3/12/2020</statusdate><chamber>Senate</chamber><action>Assigned to Insurance</action>
<statusdate>3/18/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As April 2, 2020</action>
<statusdate>3/25/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As April 24, 2020</action>
<statusdate>3/25/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Third Reading/Passage Deadline Established As May 7, 2020</action>
<statusdate>4/12/2020</statusdate><chamber>Senate</chamber><action>Pursuant to Senate Rule 3-9(b) / Referred to Assignments</action>
<statusdate>4/16/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As April 30, 2020</action>
<statusdate>4/23/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As May 7, 2020</action>
<statusdate>4/23/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Third Reading/Passage Deadline Established As May 15, 2020</action>
<statusdate>4/30/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As May 15, 2020</action>
<statusdate>4/30/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Third Reading/Passage Deadline Established As May 22, 2020</action>
<statusdate>5/7/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As May 22, 2020</action>
<statusdate>5/7/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Third Reading/Passage Deadline Established As May 29, 2020</action>
<statusdate>5/15/2020</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee/3rd Reading Deadline Established As May 31, 2020</action>
<statusdate>1/13/2021</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</actions>
</xml>

